P

Pappas Ventures

50 employees

Pappas Ventures provides investment in the life sciences sector.

Investor insights

Sectors invested in

Biotechnology32
Health Care31
Pharmaceutical14
Therapeutics12
Medical9
Medical Device7
Biopharma5
Health Diagnostics5
Genetics3
Clinical Trials2
Manufacturing2
biopharmaceuticals2
rare disease and ultra-rare disease2
research1
CA. TargeGen primarily develops small molecule kinase inhibitors for applications in oncology and inflammatory diseases.1
TargeGen1
Inc. is a privately held biopharmaceutical company based in San Diego1
Drug Discovery1
Oncology1
Life Science1

Funding rounds participated in

$23M sweet spot round size

Most of their 43 investments are in rounds between $13M and $36M

Investor type

Micro VC

Basic info

Sectors

Financial Services
Life Science
Venture Capital

Date founded

1994

Investments made

V

VelosBio Inc. raised $58M on October 1, 2018

Investors: Chiesi Ventures, Arix Bioscience plc, Sofinnova Ventures, Russia technology fund, Decheng Capital, Takeda UK Limited and Pappas Ventures

K

Kezar Life Sciences raised $50M on July 25, 2017

Investors: Chiesi Ventures, Omega Funds, Bay City Capital, AJU IB INVESTMENT, Qiming Venture Partners, Cowen Inc. and Pappas Ventures

E

Evidation Health raised $3.4M on October 11, 2016

Investors: GE Ventures, Fresco Capital, B Capital Group and Pappas Ventures

R

Rotation Medical raised $12M on August 16, 2016

Investors: EQT Life Sciences and Pappas Ventures

M

Milestone Pharmaceuticals, Inc. raised $17M on June 15, 2015

Investors: Inovia Capital, Domain Associates and Pappas Ventures

U

Undisclosed raised $21M on March 31, 2015

Investors: MP Healthcare Venture Management Inc, Advanced Technology Ventures, Lumira Ventures, S.R. One Ltd and Pappas Ventures

B

Balance Therapeutics Inc. raised $18M on March 19, 2015

Investors: Mohr Davidow Ventures and Pappas Ventures

A

Aura Biosciences raised $21M on March 5, 2015

Investors: Lysosomal Therapeutics Inc., Chiesi Ventures, Ysios Capital, Advent Life Sciences, LI-COR Biosciences and Pappas Ventures

R

Rotation Medical raised $27M on July 2, 2014

Investors: EQT Life Sciences and Pappas Ventures

L

Lumena Pharmaceuticals, Inc. raised $45M on March 11, 2014

Investors: Adage Capital Management, RiverVest Venture Partners, Alta Partners, RA Capital Management, L.P. and Pappas Ventures

FAQ